For almost 30 years, Dr. Richard Marlink helped shape the work of the Harvard AIDS Initiative (HAI). As he leaves to create and lead the Rutgers Global Health Institute, we—his colleagues at HAI— created a short video to express our appreciation of his work and gratitude for his friendship.
You don’t get much more Boston than Vincent P. McCarthy. Vin grew up in Boston’s Brighton neighborhood in the 1940s and 50s. All four of his grandparents were Irish immigrants. After graduating from Boston College in 1962 and Harvard Law School in 1965, he joined Hale and Dorr, a prominent Boston law firm. “For a peasant, I’ve had a very good life,” jokes McCarthy.
One Step Closer to Affordable HIV Drug–Resistance Test
Harvard recently entered into a licensing agreement with Aldatu Biosciences for exclusive use of the PANDAA technology. Using PANDAA, Aldatu, a biotech start-up based at LabCentral in Cambridge, is developing a rapid HIV drug-resistance test for patients failing first-line antiretroviral therapy (ART).
A lab manager is responsible for the day-to-day activities of a research laboratory, making sure that the work on the bench and behind the scenes runs smoothly. Click on image to see full infographic.
A special thanks to Don Hamel, Lab Manager of the Kanki Lab at the Harvard T. H. Chan School of Public Health
By Scott Dryden-Peterson
The 2000 International AIDS Conference in Durban was a watershed moment. Prevailing opinion turned from thinking that it was impossible to treat AIDS in Africa to believing that it was impossible and immoral not to try. Nelson Mandela, who had stepped down as president of South Africa in 1999, closed the meeting. “Let us not equivocate. A tragedy of unprecedented proportion is unfolding in Africa,” he said. “Let us combine our efforts to ensure a future for our children. The challenge is no less.”
Over 18,000 people met in Durban, South Africa this July for the 21st International AIDS Conference. We look back to a time 25 years ago, when protesters at the 1991 meeting threatened a boycott because of severe U.S. restrictions for HIV-positive travelers.
The mood in Florence was combative. It was June 1991. Scientists, activists and reporters had gathered in Italy to share the latest findings at the International AIDS Conference. Unfortunately, there were no breakthroughs to announce. Continue reading
Teenagers aren’t generally known for their self-awareness and commitment to service. Jonathan You is an exception.
The nineteen-year-old rising junior at Harvard is majoring in Molecular and Cellular Biology with a minor in Global Health and Health Policy. “My academic interest in global health was sparked by Case Studies in Global Health: Biosocial Perspectives, a class that provided me with novel viewpoints on healthcare inequity and social medicine,” he said.
Billions of dollars are spent every year on HIV/AIDS treatment programs. But how well are they working?
In the African country of Botswana, where 25% of adults (aged 16-49) are HIV positive, the answer is extremely well. In a recent paper in The Lancet HIV, researchers showed that Botswana is close to reaching the ambitious UNAIDS 90-90-90 goals. Continue reading